期刊文献+

Metabolism of Dauricine and Identification of Its Main Metabolites

Metabolism of Dauricine and Identification of Its Main Metabolites
下载PDF
导出
摘要 To study the metabolism of dauricine in vivo and in vitro and identify the structure of its main metabolites, urine of rats after drug administration as the samples of dauricine metabolism in vivo was studied. Rat liver S9 fraction was prepared and the oxygenation metabolism system reconstituted to perform phase I reaction of dauricine in vitro. TLC, HPLC DAD and MS were used to analyze and identify dauricine and its main phase I metabolites in the samples. The results showed that besides the untransformed dauricine, in the urine samples there was little product of X' which had the same features of TLC, HPLC DAD and MS as those of N desmethyl dauricine (N ddau). Part of dauricine could be transformed to a main metabolite X after incubating with S9 fraction in appropriate conditions. The molecular ion peak of X was m/z 611. The full scan MS2 spectrum of m/z 611 peak from S9 sample were m/z 580, m/z 566, m/z 552, m/z 206, which were same as those of N ddau. Liver is the major organ for dauricine metabolism and part of dauricine is biotransformed by liver. The major metabolite is considered to be N ddau. To study the metabolism of dauricine in vivo and in vitro and identify the structure of its main metabolites, urine of rats after drug administration as the samples of dauricine metabolism in vivo was studied. Rat liver S9 fraction was prepared and the oxygenation metabolism system reconstituted to perform phase I reaction of dauricine in vitro. TLC, HPLC DAD and MS were used to analyze and identify dauricine and its main phase I metabolites in the samples. The results showed that besides the untransformed dauricine, in the urine samples there was little product of X' which had the same features of TLC, HPLC DAD and MS as those of N desmethyl dauricine (N ddau). Part of dauricine could be transformed to a main metabolite X after incubating with S9 fraction in appropriate conditions. The molecular ion peak of X was m/z 611. The full scan MS2 spectrum of m/z 611 peak from S9 sample were m/z 580, m/z 566, m/z 552, m/z 206, which were same as those of N ddau. Liver is the major organ for dauricine metabolism and part of dauricine is biotransformed by liver. The major metabolite is considered to be N ddau.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2000年第3期253-256,共4页 华中科技大学学报(医学英德文版)
基金 This project was suported by a grant from the foundation of Youth Sciences and Technology Chenguang Planning ofWuhan (No.2 0
关键词 DAURICINE METABOLISM METABOLITE HPLC DAD ESI/MS dauricine metabolism metabolite HPLC DAD ESI/MS
  • 相关文献

参考文献5

  • 1刘薇薇,杜佐华,曾繁典,胡崇家,潘锡平.N-去甲基蝙蝠葛碱抗心律失常作用[J].中药药理与临床,1999,15(1):12-15. 被引量:5
  • 2潘锡平.蝙蝠葛中的新生物碱——N-去甲基蝙蝠葛碱[J].药学学报,1992,27(10):788-792. 被引量:13
  • 3Joerh L.A rapid in vitro method for the evaluation of po-tential antitumor drugs requiring metabolic activation byhepatic S9enzymes. Biochemcal Pharmacology . 1989
  • 4Vickers S.In vivo and in vitro m etabolism studies on aclass antiarrhythm ic agent. Drug Metabolism and Disposition . 1993
  • 5Chenery R J.The interaction of Om eprazole with rat liv-er cytochrome P45 0 - m ediated m onooxygenase reactionsin vitro and in vivo. Biochemcal Pharmacology . 1988

二级参考文献7

  • 1龚培力,杜佐华,曾繁典,胡崇家.蝙蝠葛酚性碱的抗心律失常作用[J].中药新药与临床药理,1995,6(3):13-16. 被引量:32
  • 2冯克燕,中华心血管病杂志,1984年,12卷,264页
  • 3郑锡文,科学通报,1979年,6期,285页
  • 4杜佐华,中药药理与临床,1996年,12卷,4期,21页
  • 5杨宝峰,中国药理学通报,1989年,5卷,2期,73页
  • 6宗贤刚,中国药理学报,1985年,6卷,1期,30页
  • 7Li G R,中医杂志,1984年,4卷,1期,25页

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部